Isabel Fragata1, Alejandro Bustamante2, Ana Penalba2, Patrícia Ferreira3, Ana Paiva Nunes3, Patrícia Canhão4,5, Joan Montaner2,6,7. 1. Neuroradiology Department, Centro Hospitalar Lisboa Central, Rua Jose Antonio Serrano, 1150-099, Lisbon, Portugal. isabelfragata@gmail.com. 2. Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain. 3. Unidade Cérebro-Vascular, Centro Hospitalar Lisboa Central, Lisbon, Portugal. 4. Department of Neurosciences and Mental Health (Neurology), Hospital de Santa Maria, Lisbon, Portugal. 5. Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal. 6. Institute de Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville, Seville, Spain. 7. Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain.
Abstract
BACKGROUND: Early cerebral hypoperfusion and ischemia occur after subarachnoid hemorrhage (SAH) and influence clinical prognosis. Pathophysiological mechanisms possibly involve inflammatory mediators. TNF-α has been associated with complications and prognosis after SAH. We investigated the relation of perfusion parameters and ischemic lesions, with levels of TNF-α main receptor, TNF-R1, after SAH, and their association with prognosis. METHODS: We included consecutive SAH patients admitted within the first 72 h of SAH onset. Blood samples were simultaneously collected from a peripheral vein and from the parent artery of the aneurysm. Levels of TNF-R1 were measured using ELISA (R&D Systems Inc., USA). CT perfusion and MRI studies were performed in the first 72 h. Correlation and logistic regression analysis were used to identify outcome predictors. RESULTS: We analyzed 41 patients. Increased levels of TNF-R1 correlated with increased Tmax (arterial: r = -0.37, p = 0.01) and prolonged MTT (arterial: r = 0.355, p = 0.012; venous: r = 0.306, p = 0.026). Increased levels of both arterial and venous TNF-R1 were associated with increased number of lesions on DWI (p = 0.006). In multivariate analysis, venous TNFR1 levels > 1742.2 pg/mL (OR 1.78; 95%CI 1.18-2.67; p = 0.006) and DWI lesions (OR 14.01; 95%CI 1.19-165.3; p = 0.036) were both independent predictors of poor outcome (mRS ≥ 3) at 6 months. CONCLUSION: Increased levels of TNF-R1 in arterial and venous blood correlate with worse cerebral perfusion and with increased burden of acute ischemic lesions in the first 72 h after SAH. Venous levels of TNF-R1 and DWI lesions were associated with poor outcome at 6 months. These results highlight the pathophysiological role of TNF-α pathways in SAH and suggest a possible role of combined imaging and laboratorial markers in determining prognosis in acute SAH.
BACKGROUND: Early cerebral hypoperfusion and ischemia occur after subarachnoid hemorrhage (SAH) and influence clinical prognosis. Pathophysiological mechanisms possibly involve inflammatory mediators. TNF-α has been associated with complications and prognosis after SAH. We investigated the relation of perfusion parameters and ischemic lesions, with levels of TNF-α main receptor, TNF-R1, after SAH, and their association with prognosis. METHODS: We included consecutive SAH patients admitted within the first 72 h of SAH onset. Blood samples were simultaneously collected from a peripheral vein and from the parent artery of the aneurysm. Levels of TNF-R1 were measured using ELISA (R&D Systems Inc., USA). CT perfusion and MRI studies were performed in the first 72 h. Correlation and logistic regression analysis were used to identify outcome predictors. RESULTS: We analyzed 41 patients. Increased levels of TNF-R1 correlated with increased Tmax (arterial: r = -0.37, p = 0.01) and prolonged MTT (arterial: r = 0.355, p = 0.012; venous: r = 0.306, p = 0.026). Increased levels of both arterial and venous TNF-R1 were associated with increased number of lesions on DWI (p = 0.006). In multivariate analysis, venous TNFR1 levels > 1742.2 pg/mL (OR 1.78; 95%CI 1.18-2.67; p = 0.006) and DWI lesions (OR 14.01; 95%CI 1.19-165.3; p = 0.036) were both independent predictors of poor outcome (mRS ≥ 3) at 6 months. CONCLUSION: Increased levels of TNF-R1 in arterial and venous blood correlate with worse cerebral perfusion and with increased burden of acute ischemic lesions in the first 72 h after SAH. Venous levels of TNF-R1 and DWI lesions were associated with poor outcome at 6 months. These results highlight the pathophysiological role of TNF-α pathways in SAH and suggest a possible role of combined imaging and laboratorial markers in determining prognosis in acute SAH.
Authors: Sherry H-Y Chou; Steven K Feske; Juli Atherton; Rachael G Konigsberg; Philip L De Jager; Rose Du; Christopher S Ogilvy; Eng H Lo; MingMing Ning Journal: J Investig Med Date: 2012-10 Impact factor: 2.895
Authors: Caron M Hong; Cigdem Tosun; David B Kurland; Volodymyr Gerzanich; David Schreibman; J Marc Simard Journal: Biomarkers Date: 2014-02-05 Impact factor: 2.658
Authors: Aaron S Dumont; Randall J Dumont; Michael M Chow; Chi-Lung Lin; Tarkan Calisaneller; Klaus F Ley; Neal F Kassell; Kevin S Lee Journal: Neurosurgery Date: 2003-07 Impact factor: 4.654
Authors: Giuseppe E Umana; S Ottavio Tomasi; Paolo Palmisciano; Gianluca Scalia; Valerio Da Ros; Rahman Al-Schameri; Stefano M Priola; Lara Brunasso; Giuseppe Roberto Giammalva; Federica Paolini; Roberta Costanzo; Lapo Bonosi; Rosa Maria Gerardi; Rosario Maugeri; Lidia Strigari; Philip E Stieg; Giuseppe Esposito; Michael T Lawton; Christoph J Griessenauer; Peter A Winkler Journal: Front Surg Date: 2022-04-05